Histone deacetylase inhibitors alter the expression of molecular markers in breast cancer cells via microRNAs.
Sign Up to like & getrecommendations! Published in 2018 at "International journal of molecular medicine"
DOI: 10.3892/ijmm.2018.3616
Abstract: Histone deacetylase inhibitors (HDACis) are able to suppress breast cancer cells in vitro and in vivo by altering the expression of estrogen receptor (ER), progesterone receptor (PR) or human epidermal growth factor receptor 2 (Her2/neu). Since HDACis can alter the expression of… read more here.
Keywords: her2 neu; bt474 cells; breast cancer; saha ... See more keywords